Supernus Pharmaceuticals buy klostergang
Start price
01.06.15
/
50%
€12.78
Target price
07.12.15
€17.00
Performance (%)
4.13%
End price
07.12.15
€13.30
Summary
This prediction ended on 07.12.15 with a price of €13.30. With a performance of 4.13%, the BUY prediction by klostergang for Supernus Pharmaceuticals closed with a slight gain. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Supernus Pharmaceuticals | -5.500% | -5.500% | 37.956% | 21.154% |
| iShares Core DAX® | -1.756% | 1.667% | 2.099% | 51.746% |
| iShares Nasdaq 100 | 2.324% | 12.779% | 38.808% | 96.064% |
| iShares Nikkei 225® | 5.022% | 13.300% | 60.099% | 71.803% |
| iShares S&P 500 | 0.802% | 6.198% | 25.356% | 68.516% |
Comments by klostergang for this prediction
In the thread Supernus Pharmaceuticals diskutieren
Entwicklung und Vermarktung von Produkten für die Behandlung des Zentralnervensystems (ZNS):
Seit 2013 mit Oxtellar XR ® und Trokendi XR ®, zwei neuartige Neurologie Produkte für die Behandlung von Epilepsie, mit steigenden Verkaufszahlen.